These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10769783)

  • 21. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D; McGinity JW
    Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
    Sawicki W; Lunio R
    Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on modifying the tackiness and drug release of Kollicoat EMM 30 D coatings.
    Erdmann H; Gebert S; Kolter K; Schepky G
    Drug Dev Ind Pharm; 2003 Apr; 29(4):429-40. PubMed ID: 12737536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
    Dave VS; Fahmy RM; Hoag SW
    Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of storage conditions and type of plasticizers on ethylcellulose and acrylate films formed from aqueous dispersions.
    Heng PW; Chan LW; Ong KT
    J Pharm Pharm Sci; 2003; 6(3):334-44. PubMed ID: 14738714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.
    Karrout Y; Siepmann F; Benzine Y; Paccou L; Guinet Y; Hedoux A; Siepmann J
    Int J Pharm; 2018 Mar; 539(1-2):39-49. PubMed ID: 29337184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alginate-magnesium aluminum silicate films: effect of plasticizers on film properties, drug permeation and drug release from coated tablets.
    Pongjanyakul T; Puttipipatkhachorn S
    Int J Pharm; 2007 Mar; 333(1-2):34-44. PubMed ID: 17056214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curing mechanism of flexible aqueous polymeric coatings.
    Irfan M; Ahmed AR; Kolter K; Bodmeier R; Dashevskiy A
    Eur J Pharm Biopharm; 2017 Jun; 115():186-196. PubMed ID: 28246029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Starch acetate--a novel film-forming polymer for pharmaceutical coatings.
    Tarvainen M; Sutinen R; Peltonen S; Tiihonen P; Paronen P
    J Pharm Sci; 2002 Jan; 91(1):282-9. PubMed ID: 11782918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The mechanical properties and moisture permeability of eudragit L100/S100 free films affected by plasticizers and membrane materials ratio].
    Zhang GS; Feng CH; Jiang W; Hu PY; Deng P; Zhang Y; Luo XJ
    Yao Xue Xue Bao; 2011 Sep; 46(9):1144-9. PubMed ID: 22121789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The permeability of enteric coatings and the dissolution rates of coated tablets.
    Porter SC; Ridgway K
    J Pharm Pharmacol; 1982 Jan; 34(1):5-8. PubMed ID: 6121034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of plasticizers on compatibility, mechanical properties, and adhesion strength of drug-free Eudragit E films.
    Lin SY; Lee CJ; Lin YY
    Pharm Res; 1991 Sep; 8(9):1137-43. PubMed ID: 1788159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.